FDA Inspection 1101342 — Michigan Reproductive Medicine
The FDA completed an inspection of Michigan Reproductive Medicine on Jul 16, 2019 in Bloomfield Hills, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 16, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Bloomfield Hills, MI (United States)